To see the full "Mad Money" Recap, please click here.

Here's what Jim Cramer had to say about some of the stocks that callers offered up during the "Mad Money Lightning Round" Wednesday evening:


Sun Microsystems ( JAVAD): "I thought the quarter was good. ... I do not think that JAVAD should be sold, but it doesn't seem to have the leverage. ... I am not going to recommend that you buy it or sell it. This is no man's land here."

DryShips ( DRYS): "I like these dry bulks, made some money. ... But we gotta wait. I cannot pull the trigger on this name."

Usana Health Sciences ( USNA): "Those things weight-loss stocks are all trading like dogs. ... I like Herbalife ( HLF) more than Usana. This group does have a stench to it, but Herbalife stinks less than the others."

Starent Networks ( STAR): "I got enough problems with these communications stocks. ... I like Vodafone ( VOD), I like Verizon ( VZ) and I like AT&T ( T)."

Wynn Resorts ( WYNN): "My personal feeling is in this market those stocks are too expensive and I'm giving you a Don'tBuy Don'tBuy. ... Let's not risk it on expensive stocks here."

Strayer Education ( STRA - Get Report): "All the education stocks are hot. I like Strayer. I like ITT Educational Services ( ESI)."

Annaly Capital Management ( NLY - Get Report): " Chairman, CEO and President Michael Farrellis about as good as it gets. Annaly goes down every time the rumor is the Fed isn't gonna cut. ... I want to bet with Mike Farrell. ... I think Annaly is one of the best stocks to own in this environment."

Mettler-Toledo ( MTD): "That's a great stock. It's had a huge run. ... It's not gonna do anything untoward to you. It's not going to break your heart. It's gonna just kinda go up over time. That's what we want."

Rogers Communications ( RCI - Get Report): "You know I like that stock. ... I like Rogers. I recommended it lower. I like Canada. ... That is my favorite stock involving media right now."

Shaw Group ( SGR): "Shaw Group, they reaffirmed their guidance. Foster Wheeler ( FWLT) is good too. ... Shaw Group's looking at a trillion dollars in business, they're looking at nuclear power. ... That's a great play."

ISIS Pharmaceuticals ( ISIS): "You know, this stock has been up up up. ... I know it has a lot of interesting drugs, but I gotta stick with my three -- Onyx Pharmaceuticals ( ONXX), Genentech ( DNA), Celgene ( CELG). I like all three of those more than ISIS."

Ctrip.com ( CTRP): "I'm using Focus Media ( FMCN), I'm using China Tel ( CHA), I'm using Baidu ( BIDU). Please don't ask me to use any more Chinese stocks."

Walter Industries ( WLT): "I cannot believe ... there wasn't really anything good in the conference call. ... It really was not a great story, but the stock's going up, which says to me SellSellSell."

Take-Two Interactive ( TTWO - Get Report): "Listen, shorty, I don't want to get anywhere near that stock. ... You want to own GameStop ( GME). ... That stock is a train wreck. I don't want you to be anywhere near that."

Want more Cramer? Check out Jim's rules and commandments for investing from his latest book by clicking here.

At the time of publication, Cramer had no positions in any of the stocks mentioned.

Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for TheStreet.com, Inc., and CNBC, and a director and co-founder of TheStreet.com. All opinions expressed by Mr. Cramer on "Mad Money" are his own and do not reflect the opinions of TheStreet.com or its affiliates, or CNBC, NBC UNIVERSAL or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither TheStreet.com, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or TheStreet.com is related to the specific opinions expressed by him on "Mad Money."

None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, TheStreet.com or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor TheStreet.com, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. When that is the case, appropriate disclosure is made on the program and in the "Mad Money" recap available on TheStreet.com. The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in TheStreet.com, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.